# Kinder Morgan, Inc.: financial statements, quarterly

KMI · NYSE · CIK 1506307 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kmi.md) · [Financials](/companies/kmi/financials.md) · [Filings](/companies/kmi/filings.md) · [Insiders](/companies/kmi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kmi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,565 d](/filings/0001506307-26-000011.md) | [3,410](/filings/0001506307-25-000022.md) | [3,213](/filings/0001506307-25-000045.md) | [3,288](/filings/0001506307-25-000065.md) | [3,572 d](/filings/0001506307-26-000011.md) | [3,862](/filings/0001506307-26-000035.md) | [3,606](/filings/0001506307-26-000085.md) | [3,723](/filings/0001506307-26-000132.md) | [4,011 d](/filings/0001506307-26-000011.md) | [4,451](/filings/0001506307-26-000035.md) | [4,098](/filings/0001506307-26-000085.md) | [4,185](/filings/0001506307-26-000132.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [1,101 d](/filings/0001506307-26-000011.md) | [1,223](/filings/0001506307-25-000022.md) | [1,038](/filings/0001506307-25-000045.md) | [1,015](/filings/0001506307-25-000065.md) | [1,108 d](/filings/0001506307-26-000011.md) | [1,145](/filings/0001506307-26-000035.md) | [1,152](/filings/0001506307-26-000085.md) | [1,063](/filings/0001506307-26-000132.md) | [1,364 d](/filings/0001506307-26-000011.md) | [1,444](/filings/0001506307-26-000035.md) | [1,346](/filings/0001506307-26-000085.md) | [1,160](/filings/0001506307-26-000132.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [206 d](/filings/0001506307-26-000011.md) | [209](/filings/0001506307-25-000022.md) | [168](/filings/0001506307-25-000045.md) | [113](/filings/0001506307-25-000065.md) | [197 d](/filings/0001506307-26-000011.md) | [186](/filings/0001506307-26-000035.md) | [177](/filings/0001506307-26-000085.md) | [185](/filings/0001506307-26-000132.md) | [284 d](/filings/0001506307-26-000011.md) | [287](/filings/0001506307-26-000035.md) | [272](/filings/0001506307-26-000085.md) | [190](/filings/0001506307-26-000132.md) |
| Net income | $m | [594 d](/filings/0001506307-26-000011.md) | [746](/filings/0001506307-25-000022.md) | [575](/filings/0001506307-25-000045.md) | [625](/filings/0001506307-25-000065.md) | [667 d](/filings/0001506307-26-000011.md) | [717](/filings/0001506307-26-000035.md) | [715](/filings/0001506307-26-000085.md) | [628](/filings/0001506307-26-000132.md) | [996 d](/filings/0001506307-26-000011.md) | [976](/filings/0001506307-26-000035.md) | [867](/filings/0001506307-26-000085.md) | [764](/filings/0001506307-26-000132.md) |
| Diluted EPS | $ per share | not reported | [0.33](/filings/0001506307-25-000022.md) | [0.26](/filings/0001506307-25-000045.md) | [0.28](/filings/0001506307-25-000065.md) | not reported | [0.32](/filings/0001506307-26-000035.md) | [0.32](/filings/0001506307-26-000085.md) | [0.28](/filings/0001506307-26-000132.md) | not reported | [0.44](/filings/0001506307-26-000035.md) | [0.39](/filings/0001506307-26-000085.md) | [0.34](/filings/0001506307-26-000132.md) |
| Basic EPS | $ per share | not reported | [0.33](/filings/0001506307-25-000022.md) | [0.26](/filings/0001506307-25-000045.md) | [0.28](/filings/0001506307-25-000065.md) | not reported | [0.32](/filings/0001506307-26-000035.md) | [0.32](/filings/0001506307-26-000085.md) | [0.28](/filings/0001506307-26-000132.md) | not reported | [0.44](/filings/0001506307-26-000035.md) | [0.39](/filings/0001506307-26-000085.md) | [0.34](/filings/0001506307-26-000132.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001506307-25-000065.md) | [0.1](/filings/0001506307-25-000022.md) | [0.1](/filings/0001506307-25-000045.md) | [0.1](/filings/0001506307-25-000065.md) | [0.1](/filings/0001506307-26-000011.md) | [0.1](/filings/0001506307-25-000022.md) | [0.1](/filings/0001506307-25-000045.md) | [0.1](/filings/0001506307-25-000065.md) | [0.1](/filings/0001506307-26-000132.md) | [0.1](/filings/0001506307-26-000035.md) | [0.1](/filings/0001506307-26-000085.md) | [0.9](/filings/0001506307-26-000132.md) |
| Current assets | $bn | [2.5](/filings/0001506307-25-000008.md) | [2.3](/filings/0001506307-24-000031.md) | [2.2](/filings/0001506307-24-000074.md) | [2.2](/filings/0001506307-24-000119.md) | [2.5](/filings/0001506307-26-000011.md) | [2.6](/filings/0001506307-25-000022.md) | [2.5](/filings/0001506307-25-000045.md) | [2.4](/filings/0001506307-25-000065.md) | [2.8](/filings/0001506307-26-000132.md) | [2.7](/filings/0001506307-26-000035.md) | [2.6](/filings/0001506307-26-000085.md) | [3.5](/filings/0001506307-26-000132.md) |
| Total assets | $bn | [71.0](/filings/0001506307-25-000008.md) | [70.7](/filings/0001506307-24-000031.md) | [70.7](/filings/0001506307-24-000074.md) | [70.9](/filings/0001506307-24-000119.md) | [71.4](/filings/0001506307-26-000011.md) | [72.3](/filings/0001506307-25-000022.md) | [72.4](/filings/0001506307-25-000045.md) | [72.3](/filings/0001506307-25-000065.md) | [72.7](/filings/0001506307-26-000132.md) | [73.1](/filings/0001506307-26-000035.md) | [74.1](/filings/0001506307-26-000085.md) | [75.4](/filings/0001506307-26-000132.md) |
| Current liabilities | $bn | [7.2](/filings/0001506307-25-000008.md) | [4.6](/filings/0001506307-24-000031.md) | [6.0](/filings/0001506307-24-000074.md) | [4.7](/filings/0001506307-24-000119.md) | [5.1](/filings/0001506307-26-000011.md) | [5.8](/filings/0001506307-25-000022.md) | [3.6](/filings/0001506307-25-000045.md) | [3.8](/filings/0001506307-25-000065.md) | [4.3](/filings/0001506307-26-000132.md) | [5.2](/filings/0001506307-26-000035.md) | [5.6](/filings/0001506307-26-000085.md) | [5.2](/filings/0001506307-26-000132.md) |
| Total liabilities | $bn | [39.3](/filings/0001506307-25-000008.md) | [39.0](/filings/0001506307-24-000031.md) | [39.0](/filings/0001506307-24-000074.md) | [39.1](/filings/0001506307-24-000119.md) | [39.5](/filings/0001506307-26-000011.md) | [40.4](/filings/0001506307-25-000022.md) | [40.3](/filings/0001506307-25-000045.md) | [40.3](/filings/0001506307-25-000065.md) | [40.3](/filings/0001506307-26-000132.md) | [40.5](/filings/0001506307-26-000035.md) | [41.2](/filings/0001506307-26-000085.md) | [42.6](/filings/0001506307-26-000132.md) |
| Long-term debt | $bn | [28.1](/filings/0001506307-25-000008.md) | [30.2](/filings/0001506307-24-000031.md) | [28.6](/filings/0001506307-24-000074.md) | [30.0](/filings/0001506307-24-000119.md) | [29.9](/filings/0001506307-26-000011.md) | [30.0](/filings/0001506307-25-000022.md) | [31.9](/filings/0001506307-25-000045.md) | [31.5](/filings/0001506307-25-000065.md) | [30.8](/filings/0001506307-26-000132.md) | [29.9](/filings/0001506307-26-000035.md) | [29.8](/filings/0001506307-26-000085.md) | [31.3](/filings/0001506307-26-000132.md) |
| Current portion of debt | $bn | [4.0](/filings/0001506307-25-000008.md) | [2.0](/filings/0001506307-24-000031.md) | [3.1](/filings/0001506307-24-000074.md) | [2.0](/filings/0001506307-24-000119.md) | [2.0](/filings/0001506307-26-000011.md) | [3.0](/filings/0001506307-25-000022.md) | [0.8](/filings/0001506307-25-000045.md) | [1.1](/filings/0001506307-25-000065.md) | [1.2](/filings/0001506307-26-000132.md) | [2.2](/filings/0001506307-26-000035.md) | [2.4](/filings/0001506307-26-000085.md) | [1.7](/filings/0001506307-26-000132.md) |
| Shareholders' equity | $bn | [30.3](/filings/0001506307-25-000008.md) | [30.4](/filings/0001506307-24-000031.md) | [30.3](/filings/0001506307-24-000074.md) | [30.4](/filings/0001506307-24-000119.md) | [30.5](/filings/0001506307-26-000011.md) | [30.6](/filings/0001506307-25-000022.md) | [30.8](/filings/0001506307-25-000045.md) | [30.7](/filings/0001506307-25-000065.md) | [31.2](/filings/0001506307-26-000132.md) | [31.3](/filings/0001506307-26-000035.md) | [31.6](/filings/0001506307-26-000085.md) | [31.6](/filings/0001506307-26-000132.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,322 d](/filings/0001506307-26-000011.md) | [1,189](/filings/0001506307-25-000022.md) | [1,687 d](/filings/0001506307-25-000045.md) | [1,249 d](/filings/0001506307-25-000065.md) | [1,510 d](/filings/0001506307-26-000011.md) | [1,162](/filings/0001506307-26-000035.md) | [1,649 d](/filings/0001506307-26-000085.md) | [1,414 d](/filings/0001506307-26-000132.md) | [1,692 d](/filings/0001506307-26-000011.md) | [1,491](/filings/0001506307-26-000035.md) | [1,960 d](/filings/0001506307-26-000085.md) | [1,590 d](/filings/0001506307-26-000132.md) |
| Capital expenditure | $m | [628 d](/filings/0001506307-26-000011.md) | [619](/filings/0001506307-25-000022.md) | [581 d](/filings/0001506307-25-000045.md) | [657 d](/filings/0001506307-25-000065.md) | [772 d](/filings/0001506307-26-000011.md) | [766](/filings/0001506307-26-000035.md) | [647 d](/filings/0001506307-26-000085.md) | [793 d](/filings/0001506307-26-000132.md) | [820 d](/filings/0001506307-26-000011.md) | [804](/filings/0001506307-26-000035.md) | [982 d](/filings/0001506307-26-000085.md) | [1,045 d](/filings/0001506307-26-000132.md) |
| Dividends paid | $m | [631 d](/filings/0001506307-26-000011.md) | [631](/filings/0001506307-25-000022.md) | [641 d](/filings/0001506307-25-000045.md) | [643 d](/filings/0001506307-25-000065.md) | [642 d](/filings/0001506307-26-000011.md) | [642](/filings/0001506307-26-000035.md) | [654 d](/filings/0001506307-26-000085.md) | [654 d](/filings/0001506307-26-000132.md) | [654 d](/filings/0001506307-26-000011.md) | [654](/filings/0001506307-26-000035.md) | [665 d](/filings/0001506307-26-000085.md) | [665 d](/filings/0001506307-26-000132.md) |
| Share repurchases | $m | [132 d](/filings/0001506307-26-000011.md) | [7.0](/filings/0001506307-25-000022.md) | [0.0 d](/filings/0001506307-25-000045.md) | [0.0 d](/filings/0001506307-25-000065.md) | [0.0 d](/filings/0001506307-26-000011.md) | [0.0](/filings/0001506307-25-000022.md) | [0.0 d](/filings/0001506307-25-000045.md) | [0.0 d](/filings/0001506307-25-000065.md) | [0.0 d](/filings/0001506307-26-000011.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2,247](/filings/0001506307-24-000031.md) | [2,237](/filings/0001506307-24-000074.md) | [2,230](/filings/0001506307-24-000119.md) | [2,220](/filings/0001506307-25-000022.md) | [2,219](/filings/0001506307-25-000045.md) | [2,221](/filings/0001506307-25-000065.md) | [2,222](/filings/0001506307-26-000035.md) | [2,222](/filings/0001506307-26-000085.md) | [2,224](/filings/0001506307-26-000132.md) | [2,225](/filings/0001506307-26-000035.md) | [2,225](/filings/0001506307-26-000085.md) | [2,227](/filings/0001506307-26-000132.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,227,715,229 at 2026-10-22, from the cover of the [10-Q filed 2026-10-23](/filings/0001506307-26-000132.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.